Hemofília: nyitott vizsgálatok itt: Kanada

• NCT06941870

  Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

  Kísérleti kezelés · 4. fázis · Sanofi

  Calgary · Hamilton · Hamilton · St. John's

  Regiszter frissítve: 2026-11-09

• NCT05987449

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

  Kísérleti kezelés · 1/2. fázis · Hoffmann-La Roche

  Hamilton Health Sciences Corporation, Hamilton · British Columbia Children's Hospital, Vancouver

  Regiszter frissítve: 2026-11-05

• NCT07416604

  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  Kísérleti kezelés · 3. fázis · Hoffmann-La Roche

  London Health Sciences Centre, London

  Regiszter frissítve: 2026-11-03

• NCT07830732

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  Kísérleti kezelés · 3. fázis · Novo Nordisk A/S

  McMaster University, Hamilton · St. Michael's Hospital, Toronto · St Pauls Hospital, Vancouver

  Regiszter frissítve: 2026-10-28

• NCT07285460

  A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

  Kísérleti kezelés · 3. fázis · Sanofi

  Hamilton · Montreal · Toronto

  Regiszter frissítve: 2026-10-27

• NCT05145127

  Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors

  Kísérleti kezelés · 3. fázis · Pfizer

  Stollery Children'S Hospital, Edmonton · Hamilton Health Sciences - McMaster University Medical Centre, Hamilton

  Regiszter frissítve: 2026-10-26

• NCT07088458

  An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A

  Kutatás · Bayer

  Many Locations, Many Locations

  Regiszter frissítve: 2026-10-26

• NCT06379789

  A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

  Kísérleti kezelés · 1/2. fázis · Regeneron Pharmaceuticals

  University of Alberta Hospital, Edmonton · McMaster University Medical Centre, Hamilton Health Sciences, Hamilton · Mcgill University Health Center (MUHC), Montreal

  Regiszter frissítve: 2026-10-21

• NCT05611801

  A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

  Kísérleti kezelés · 3. fázis · Pfizer

  Stollery Children'S Hospital, Edmonton · Hamilton Health Sciences - McMaster University/McMaster Children's Hospital, Hamilton

  Regiszter frissítve: 2026-10-14

• NCT07452575

  3D Ultrasound in Hemophilic Ankles

  Kísérleti kezelés · The Hospital for Sick Children

  The Hospital for Sick Children, Toronto

  Regiszter frissítve: 2026-10-14

• NCT05568719

  Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  Kísérleti kezelés · 3. fázis · Pfizer

  Unity Health Toronto, St. Michael's Hospital, Toronto

  Regiszter frissítve: 2026-10-07

• NCT06003387

  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  Kísérleti kezelés · 3. fázis · CSL Behring

  McMaster University - Hamilton, Hamilton

  Regiszter frissítve: 2026-08-27

• NCT04278404

  Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  Kutatás · Duke University

  CHU Sainte-Justine, Montreal · The Hospital for Sick Children, Toronto

  Regiszter frissítve: 2026-08-21

• NCT06349473

  A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  Kísérleti kezelés · 1. fázis · Equilibra Bioscience LLC

  McMaster University Medical Centre, Hamilton Health Sciences, Hamilton

  Regiszter frissítve: 2026-07-02

• NCT03745924

  A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN

  Kutatás · Novo Nordisk A/S

  University of Calgary Cumming School of Medicine, Calgary · Univ of Alberta Hospital Res, Edmonton · Hamltn Hth Sci/McMstr Child Hosp, Hamilton · Hamilton Health Sciences Corp, Ontario, Hamilton · Health Science Centre, St. John's · The Hospital for Sick Children, Toronto · CancerCare Manitoba, Winnipeg

  Regiszter frissítve: 2026-06-12

• NCT03695978

  Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

  Kutatás · Octapharma

  Department of Hematology Research Research Transition Facility, Edmonton · McMaster University, Division of Pediatric Hematology/Oncology Room 3N27, Hamilton

  Regiszter frissítve: 2026-06-02

• NCT02979119

  The European Paediatric Network for Haemophilia Management ( PedNet Registry)

  Kutatás · PedNet Haemophilia Research Foundation

  Division of Hematology/Oncology Hôpital St Justine, Montreal · Division of Haematology/Oncology Hospital for Sick Children, Toronto

  Regiszter frissítve: 2025-09-16

• NCT03549858

  Patient Reported Outcomes Burdens and Experiences - Phase 3

  Kutatás · McMaster University

  McMaster University, Hamilton

  Regiszter frissítve: 2025-08-22

• NCT03327779

  World Bleeding Disorders Registry

  Kutatás · World Federation of Hemophilia

  World Federation of Hemophilia, Montreal

  Regiszter frissítve: 2023-08-14

Minden vizsgálat (Hemofília) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek